PACTR201909557694667CompletedPhase 4
Intraoperative effects of dexmedetomidine infusion in adult living donors undergoing hepatic resections for liver transplantation: A randomized control trial.
national liver institute menoufeya university0 sites40 target enrollmentStarted: August 20, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 19 Year(s) to 44 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •All donors fulfilled the eligibility criteria for donation including a within normal liver histology and a volumetric study of the whole liver and the right lobe.Age 18-45 years old, ASA I, normal liver functions, coagulation profiles and normal renal functions.
Exclusion Criteria
- •inability to give written consent, hemoglobin level < 10 g/dl. Any contraindication for donation.
Investigators
Similar Trials
Recruiting
Not Applicable
Dexmedetomidine infusion during Adult Living Donor Liver TransplantatioDigestive SystemSurgeryDonor Liver TransplantationPACTR201408000872245ational liver institute40
Not yet recruiting
Not Applicable
Effect of dexmedetomidine (type of pain killer) injection on pain, heart rate and blood pressure in patients undergoing laparoscopic (minimally invasive) operations.CTRI/2022/10/046808Dr Lokeshwaran
Completed
Not Applicable
Effect of drug given during spine surgery for old aged patients on Recovery and mentatioCTRI/2020/06/026077Indraprastha Apollo Hospital New Delhi60
Not yet recruiting
Phase 4
use of dexmedetomidine infusion in diabetic patients undergoing laparoscopic cholecystectomy.CTRI/2023/01/049274simmi kishore
Unknown
Not Applicable
Effect of perioperative Dexmedetomidine infusion on blood glucose levels in non diabetic morbid obese patients undergoing laparoscopic bariatric surgeSurgeryPACTR201604001510193Raham Hasan60